Evidence map›Paper›PMID 29442173›Full record

ArticleMedical oncology (Northwood, London, England)2018

Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation.

Roberto Orecchia, Damaris Patricia Rojas, Federica Cattani, Rosalinda Ricotti, Luigi Santoro, Anna Morra, Raffaella Cambria, Rosa Luraschi, Samantha Dicuonzo, Sara Ronchi and 7 more

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Roberto OrecchiaDepartment of Medical Imaging and Radiation Sciences, European Institute of Oncology, Milan, Italy.
Damaris Patricia RojasDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Federica CattaniUnit of Medical Physics, European Institute of Oncology, Milan, Italy.
Rosalinda RicottiDivision of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
Luigi SantoroDivision of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
Anna MorraDivision of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
Raffaella CambriaUnit of Medical Physics, European Institute of Oncology, Milan, Italy.
Rosa LuraschiUnit of Medical Physics, European Institute of Oncology, Milan, Italy.
Samantha DicuonzoDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Sara RonchiDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Alessia SurgoDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Veronica Dell' AcquaDivision of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
Paolo VeronesiDivision of Breast Surgery, European Institute of Oncology, Milan, Italy.
Francesca De LorenziDivision of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy.
Cristiana FodorDivision of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
Maria Cristina LeonardiDivision of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. cristina.leonardi@ieo.it.ORCID http://orcid.org/0000-0001-6529-8328
Barbara Alicja Jereczek-FossaDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the dosimetry and toxicity of hypofractionation in postmastectomy radiotherapy (PMRT) with intensity-modulated radiotherapy (IMRT) in breast cancer (BC) patients. Stage II-III BC patients with implant-based immediate breast reconstruction received PMRT to the chest wall (CW) and to the infra/supraclavicular nodal region (NR) using a 15-fraction schedule (2.67 Gy/fraction) and helical IMRT (Tomotherapy

Indexed as

MammaplastySeverity of Illness IndexBreast NeoplasmsDermatitisDose Fractionation, RadiationFemaleFollow-Up StudiesHumansMastectomyMiddle AgedOrgans at RiskPrognosisRadiotherapy DosageRadiotherapy, Intensity-ModulatedRisk FactorsHypofractionationImmediate breast reconstructionLocoregional radiotherapyTomotherapyToxicity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.